A Study of JZP541 in Adults With Irritability Associated With Autism Spectrum Disorder
Status:
Not yet recruiting
Trial end date:
2025-03-01
Target enrollment:
Participant gender:
Summary
Behavior dysregulation is commonly associated with people with autism spectrum disorder
(ASD). Irritability is a major safety concern in adults with ASD. This study will assess the
efficacy and safety of JZP541 in the treatment of adults with irritability associated with
ASD.